borderline significanceP = 0.050
7 A), IFIH1 and ISG15 showed no significant association with late-stage RA, while CXCL10 demonstrated borderline significance (OR = 2.170, P = 0.050).
7 A), IFIH1 and ISG15 showed no significant association with late-stage RA, while CXCL10 demonstrated borderline significance (OR = 2.170, P = 0.050).